(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RYBELSUS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

RYBELSUS

ST13

US500000079413748

Class

5

Filing

79413748

Registration

8122510

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

08/10/2026

Classification

Registered

Trademark type

Combined

Nice classes

5

Filing date

08/28/2024

Registration date

02/03/2026

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/03/2026

Last transaction

08/10/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

99

Owner location

DK

Examiner

LAPTER, ALAIN J

Law office

L50

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the term RYBELSUS in stylized font in the colors purple and orange.

Holders and representatives

Holders

Novo Nordisk A/S

Representatives

Emily Barnhart

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of diabetes.

Publications

History of USPTO decisions and trademark events.

27 publications found

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/10/2026

FIMP

FINAL DISPOSITION PROCESSED

08/10/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

06/18/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

06/01/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

05/31/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/03/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/03/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

02/03/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/16/2025

PUBO

PUBLISHED FOR OPPOSITION

12/16/2025

GPNX

NOTIFICATION PROCESSED BY IB

12/11/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/10/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/26/2025

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/25/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/16/2025

RFNT

REFUSAL PROCESSED BY IB

11/15/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/11/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/11/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/11/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/24/2025

RFRR

REFUSAL PROCESSED BY MPU

10/24/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/09/2025

CNRT

NON-FINAL ACTION WRITTEN

09/08/2025

DOCK

ASSIGNED TO EXAMINER

09/06/2025

MAFR

APPLICATION FILING RECEIPT MAILED

09/05/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/05/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/02/2025

Continuous trademark protection

Get notified about every new filing that threatens RYBELSUS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.